A comparison of the abuse experiences of male and female adults molested as children

Do the molestation experiences of boys and girls differ? The present study analyzed data from 365 adults molested as children, and compared findings for males and females on the identity of the perpetrator, age at onset and end of molestation, duration of molestation, type of sexual acts, and whether the molestation was reported to law enforcement. Results indicated that boys and girls were equally likely to be molested by natural fathers, girls were more likely to be molested by stepfathers, and boys were more likely to be molested by friends of the family. Molestation started at the same age for boys and girls, but lasted longer and ended at a later age for girls. Males and females were equally likely to experience fondling from the waist down and oral intercourse. However, there were significant differences for incidence of anal intercourse and fondling from the waist up. Findings are discussed in the context of previous research in the field.     

Queer(y)ing Hannah Arendt,or what’s Hannah Arendt got to do with intersectionality?

Abstract

This article takes an unlikely approach to thinking about intersectionality theory. Exploring key concepts from the writings of Hannah Arendt, such as plurality, conscious pariah, and statelessness, alongside her embodied interrogation of anti-Semitism and the Jewish Question, it suggests a way to transgress the ordinary boundaries of the concepts of queer, international, and feminist and, conversely, to unbound the ordinary ways Arendt’s theories have been interpreted as less relevant, if not antithetical to, feminist, intersectional, and queer theories and politics.     

Rethinking risk in pediatric research

This article reviews four areas of pediatric research in which we have identified questionable levels of allowable risk, exceeding those foreseen by the Commission. They are the following: (1) the categorization of increasingly risky interventions as minimal risk in a variety of protocols; (2) the increasing number of applications for federal panel review of research not otherwise approvable because of higher projected risk levels; (3) research on asymptomatic at risk children; and (4) the inclusion of children and adolescents in placebo-controlled trials for participants of all ages without performing subgroup analysis. While embracing the imperative to include children in research is an encouraging step towards providing the pediatric population with effective medical care and finally eradicating the therapeutic orphan, we must ensure that this research does not become overly permissive.